The CCL5/CCR5 axis promotes metastasis in basal breast cancer

CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells

(2012) M. Velasco-Velazquez et al.   CANCER RESEARCH

Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

(2011) Michael O. Meyers et al.   ANNALS OF SURGICAL ONCOLOGY

RB-pathway disruption in breast cancer

(2010) Adam Ertel et al.   CELL CYCLE

Three-Year Safety and Efficacy of Vicriviroc, a CCR5 Antagonist, in HIV-1–Infected Treatment-Experienced Patients

(2010) Timothy J Wilkin et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Metastatic Behavior of Breast Cancer Subtypes

(2010) Hagen Kennecke et al.   JOURNAL OF CLINICAL ONCOLOGY

CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation

(2009) Thomas T. Murooka et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS